Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-23

Clinical Trial Update: Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of tirzepatide in combination with insulin glargine on glucolipid metabolism and brain function in patients with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: RECRUITING